Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle J Groome

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2015
Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African InfantsSung-Sil Moon, Michelle J Groome, Daniel E Velasquez, et al.
The Pediatric Infectious Disease Journal|February 27, 2014
Impact of rotavirus vaccine on childhood diarrheal hospitalization after introduction into the South African public immunization programVeerle M Y Msimang, Nicola Page, Michelle J Groome, et al.
Pediatrics|August 8, 2012
Maternal HIV infection and vertical transmission of pathogenic bacteriaClare L Cutland, Stephanie J Schrag, Elizabeth R Zell, et al.
The Lancet. Infectious Diseases|May 10, 2017
Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trialMichelle J Groome, Anthonet Koen, Alan Fix, et al.
Vaccine|December 27, 2014
Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of ageMarta C Nunes, Stephanie A Jones, Michelle J Groome, et al.
Lancet (London, England)|June 28, 2025
How Gavi support for RSV immunisation will advance health equityHellen C Barsosio, Louis J Bont, Michelle J Groome, et al.
Emerging Infectious Diseases|March 27, 2015
Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1)Clare L Cutland, Stephanie J Schrag, Michael C Thigpen, et al.
Thorax|June 21, 2015
Effectiveness of pneumococcal conjugate vaccine against presumed bacterial pneumonia hospitalisation in HIV-uninfected South African children: a case-control studyShabir A Madhi, Michelle J Groome, Heather J Zar, et al.
The Pediatric Infectious Disease Journal|June 9, 2016
Risk Factors for Presumed Bacterial Pneumonia Among HIV-uninfected Children Hospitalized in Soweto, South AfricaJennifer R Verani, Michelle J Groome, Heather J Zar, et al.
Vaccine|April 3, 2025
Effectiveness of BNT162b2 and Ad26.COV2.S vaccines against COVID-19-related hospitalisation amongst adult members of a private health insurance plan in South Africa during the Delta and Omicron periods: A test-negative case-control studySiobhan L Johnstone, Daniel Shapiro, Nicola Chiwandire, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2015
Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African InfantsSung-Sil Moon, Michelle J Groome, Daniel E Velasquez, et al.
The Pediatric Infectious Disease Journal|February 27, 2014
Impact of rotavirus vaccine on childhood diarrheal hospitalization after introduction into the South African public immunization programVeerle M Y Msimang, Nicola Page, Michelle J Groome, et al.
Pediatrics|August 8, 2012
Maternal HIV infection and vertical transmission of pathogenic bacteriaClare L Cutland, Stephanie J Schrag, Elizabeth R Zell, et al.
The Lancet. Infectious Diseases|May 10, 2017
Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trialMichelle J Groome, Anthonet Koen, Alan Fix, et al.
Vaccine|December 27, 2014
Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of ageMarta C Nunes, Stephanie A Jones, Michelle J Groome, et al.
Lancet (London, England)|June 28, 2025
How Gavi support for RSV immunisation will advance health equityHellen C Barsosio, Louis J Bont, Michelle J Groome, et al.
Emerging Infectious Diseases|March 27, 2015
Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1)Clare L Cutland, Stephanie J Schrag, Michael C Thigpen, et al.
Thorax|June 21, 2015
Effectiveness of pneumococcal conjugate vaccine against presumed bacterial pneumonia hospitalisation in HIV-uninfected South African children: a case-control studyShabir A Madhi, Michelle J Groome, Heather J Zar, et al.
The Pediatric Infectious Disease Journal|June 9, 2016
Risk Factors for Presumed Bacterial Pneumonia Among HIV-uninfected Children Hospitalized in Soweto, South AfricaJennifer R Verani, Michelle J Groome, Heather J Zar, et al.
Vaccine|April 3, 2025
Effectiveness of BNT162b2 and Ad26.COV2.S vaccines against COVID-19-related hospitalisation amongst adult members of a private health insurance plan in South Africa during the Delta and Omicron periods: A test-negative case-control studySiobhan L Johnstone, Daniel Shapiro, Nicola Chiwandire, et al.
Pageof 7